Sun, Jul 13, 2014, 7:27 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Given Imaging Ltd. (GIVN) Message Board

dontdropyourlunch 52 posts  |  Last Activity: Jul 2, 2014 8:42 PM Member since: May 9, 2000
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • dontdropyourlunch by dontdropyourlunch Apr 23, 2014 4:24 AM Flag

    April 22 the FDA granted Bayer's Ciprofloxacin dry powder inhaler for the treatment of non-cystic fibrosis bronchiectasis receives orphan designation status. It is interesting one link you will find when you Google ciprofloxacin dry powder inhaler is a paper on this inhaled dry powder drug used for COPD. It seemed like ironic recursion.

  • dontdropyourlunch dontdropyourlunch Apr 21, 2014 12:19 PM Flag

    billy.simms, you may be the real Billy Sims of football fame, because your grammar lesson for me is incorrect. You can either use "has run" or simply "ran" to describe your communication, but "has ran" is what you incorrectly wrote. Just FYI present perfect tense does describe something in the past.

    I suppose marty.mckenney798 just cut and pasted what you wrote, and that is how the identical post appeared under both handles about the same time.

    I have no doubt you want CHK's stock price to go up, but you do not appear to see reasons for it to go up. I do even sometime after this next earnings report. I cannot say there will not be a slight pullback after earnings, but CHK is at the top of a weekly channel. It looks like a breakout over the channel top is coming. CHK has already broken out (March 2014) from a daily bull flag chart pattern going back to November 2013.

  • John Murphy's Stockcharts website Market Message tab for Thursday April 17 at 10:33 pm shows charts 9 and 10 for the natural gas index end of day spot prices. Chart 9 shows the daily ng price, and he says the closing price at 4.74 has broken out of resistance. Also he writes it has made a new high for the 2nd week. In chart 10 he shows a weekly log chart of ng with an upward channel starting in April 2012, and ng is at the bottom of that channel today. The top of that channel today is at about 6.65.

  • Saturday I noticed the reply to one of my posts (quoted below) by billy.simms, and a while later under the Cline Shale Formation topic I noticed the identical post from marty.mckenney798 with the identically wrong spelling of the present perfect tense of the verb to run. Then I noticed under the Life Changer topic marty.mckenney798 is pumping some site that he says is making him a lot of money. Marty and billy may be the same person on this CHK board acting interested in order to sell some website data. Who knows, but FYI.

    billy and marty wrote, "The stock has ran this way the past few times going into earning and tanked afterwards. Why is this time different?"

  • dontdropyourlunch dontdropyourlunch Apr 19, 2014 10:54 PM Flag

    dmorgan2151, when I drew the various trendlines that I can see in CHK's past years, I see two prices as of today CHK should reach to get back on either of those trends. If I draw the trendline starting from about April 2003, CHK would need to be 48 to be on that long term trendline. If I draw the trendline starting from December 2008, CHK would need to be about 38 to be on that long term trendline. These long term trendlines have interesting ways to have a stock price get back on the long term trendlines after they have broken down for a long time. Often when we see a stock moving strongly higher in a short span of time, it is an indication the price is trying hard to get back on an old trendline. Since CHK has made a lot of changes for the good with equipment, efficiency, financials and debt, and personnel, let's see what happens with the added positive of higher natural gas prices.

  • dontdropyourlunch dontdropyourlunch Apr 18, 2014 6:04 PM Flag

    dmorgan2151, why did you pick 33 instead of 34? 34 was the last high set in February and August 2011.

  • Reply to

    Cramer just #$%$ on MNKD

    by cvs9yt Apr 17, 2014 7:09 PM
    dontdropyourlunch dontdropyourlunch Apr 17, 2014 11:28 PM Flag

    cvs9yt, I went to the video and watched it from 4/17/14, and Cramer said he was not going to say anything negative because MNKD is a cult stock and it will overload his twitter account the next four days telling him what a jerk he is. He did mention in a goofy way the small device. He said he does not know how big the device is going to be (meaning, I think, he does not know how successful Afrezza is going to be). He said he is critical and remains skeptical. Ja und. He is skeptical, because AF of some short buddy told him to be skeptical.

    Don't get fumed over Cramer's ignorance. Several years ago when I owned SSYS at much lower prices, someone called in about it. He knew nothing but said don't buy. Maybe 60 points higher he loved SSYS.

    Since the FDA staff people at the AdCom did not understand the diabetic's blood sugar control problem other than through their A1c benchmark until the AdCom panel of doctors/scientists and mostly the diabetics' testimonials explained it to them, how can we expect a momentum stock jock/yell king, Cramer, to have any idea what he might think if he understood the blood sugar control problem. No one has explained it to him, and he would not understand the chemical mechanism anyway. Cramer will love Afrezza in a year, and wear a post-it to tell all how wrong he has been. Of course that is not good enough, but he did not know anything about SSYS at 25 and still #$%$ on it in his lightning round. I know he has loved it in the past 12 months or more around 100.

  • Reply to

    FDA panel members - details

    by matese16 Apr 17, 2014 11:16 AM
    dontdropyourlunch dontdropyourlunch Apr 17, 2014 1:09 PM Flag

    turk_74, your various reasoned replies confused me, and I think I figured out why. In your three different replies, you mixed staff and panel in one of your replies(specifically the 2nd reply timewise). I believe you corrected your meaning with your third post reply in this thread. Just for completeness in order that I might have it clear in my reading: When I think staff, you meant the staff people who work for the FDA who were sitting there at the table. When I think panel, you meant the various invited doctors/scientists who were also sitting at the tables, and in addition the people who voted 13-1 and 14--0 in favor of Type 1 and Type 2, respectively. If I am wrong, please correct me.

  • Reply to

    question for afrezzauser

    by rambleon_12 Apr 7, 2014 2:42 PM
    dontdropyourlunch dontdropyourlunch Apr 16, 2014 4:46 PM Flag

    seagate48, you can buy a DVD or watch the video of the entire MNKD AdCom by going to fdalive . You can guess the rest of the suffix for fdalive, but I have to write it this way for Yahoo not to delete the post. Their autodeleter software appears to have eaten my prior post to you when I used the word period between the term and the suffix.

  • Reply to

    jimbering

    by new21yroldinvestor Apr 16, 2014 3:23 PM
    dontdropyourlunch dontdropyourlunch Apr 16, 2014 4:01 PM Flag

    new21yroldinvestor, you did get the lying use, as in reclining, right. But mercy, are you aware the tenses in all your other sentences are totally incorrect? You need to hit the books on the use of adverbs too. In your college are you still able to take some remedial grammar course or courses? In your effort to teach people the correct use of to lie instead of to lay in the reclining sense, you have exposed your flank in other areas of grammar. You sound like someone who wants to learn, and you have some learning to do in English. My degrees have nothing to do with English, but I had a good grammar teacher in middle school. I don't normally rag on the often poorly written posts on Yahoo, but when someone wants to teach others, perhaps that person can learn something too. Maybe English is not your mother tongue, i.e., first language.

  • Reply to

    potential competition?

    by findingomega Apr 11, 2014 10:21 AM
    dontdropyourlunch dontdropyourlunch Apr 14, 2014 11:46 AM Flag

    jstokcton, why don't you read the S1 that Dance has on file with the SEC since about April 9th? It has all the details and curves you need to know and understand. It is clear from their PK information, Dance looks just like the insulin analogs that are on the market today and the past many years -- long tails and all to get out of the system and cause hypos. They show their curves to look just like Humalog. Is everyone here so lazy, or do they just not know how to do the simplest research. The device information is also in the S1 including who makes it for Dance and how it functions (with batteries it appears), etc., etc.

    If Dance really does an IPO, it is just to get some of the founders and investors out with some money in their pockets. I have already posted some days ago that Dance should go the Kickstarter route instead of an IPO.

  • dontdropyourlunch dontdropyourlunch Apr 13, 2014 7:38 PM Flag

    Almost everyone knows SA authors are compensated for their writings. Why the question? This fellow knows the more controversy he raises among readers, the more money he will make. Is this really news to Yahoo message board readers. SA has posted the rates it pays. I have read it before on the SA site. Of course he could be getting paid by someone else to write too. Just double dipping I suppose.

GIVN
29.980.00(0.00%)Feb 26 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.